Galena Biopharma plans to conduct public sale of common-share units

Company to sell shares with warrants through bookrunner Raymond James

By Wendy Van Sickle

Columbus, Ohio, Jan. 6 – Galena Biopharma, Inc. said it will price a public offering of units.

The units consist of common shares and warrants.

Raymond James is the bookrunning manager.

Proceeds will be used to fund the company’s ongoing Phase 3 Present study and other clinical trials of its product candidates, to augment its working capital and for general corporate purposes.

Galena is a biotechnology company based in Lake Oswego, Ore.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.